Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. Y. van Sleen

Publications

Distinct landscapes of fibroblast subtypes in arteries of patients with giant cell arteritis

GM-CSF drives IL-6 production by macrophages in polymyalgia rheumatica

Altered plasma levels and tissue expression of fibroblast activation protein alpha in giant cell arteritis

Clonal hematopoiesis and UBA1 mutations in individuals with biopsy-proven giant cell arteritis and population-based controls

Effects of ageing and frailty on circulating monocyte and dendritic cell subsets

Humoral SARS-CoV-2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the Booster

Impaired IL-6-induced JAK-STAT signaling in CD4+ T cells associates with longer treatment duration in giant cell arteritis

mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy

Multiple vaccine comparison in the same adults reveals vaccine-specific and age-related humoral response patterns: an open phase IV trial

Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

Press/media

How Does COVID-19 Booster Affect Patients With GCA and Low Primary Vaccine Response?

Biomarkers may improve giant cell arteritis diagnosis

Vasculitis Foundation: international research insights